Renal Cancer - Results from #1220

An exploratory study of CT radiomics using differential network feature selection for WHO/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma. November 21, 2022

LINC00472 inhibits cell migration by enhancing intercellular adhesion and regulates H3K27ac level via interacting with P300 in renal clear cell carcinoma. November 18, 2022

Novel Retroperitoneal Neovascularity Scoring System in Renal Cell Carcinoma Tumor Staging. November 18, 2022

A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy--A large, retrospective, single-center study. November 17, 2022

Hot topics in renal cancer pathology: implications for clinical management. November 17, 2022

An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas. November 16, 2022

Predicting short- and long-term renal function following partial and radical nephrectomy. November 16, 2022

Impact of Partial Nephrectomy and Percutaneous Cryoablation on Short-term Health-related Quality of Life-A Prospective Comparative Cohort Study. November 15, 2022

Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma. November 15, 2022

Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade. November 15, 2022

NFE2L3 as a Potential Functional Gene Regulating Immune Microenvironment in Human Kidney Cancer. November 14, 2022

FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy. November 14, 2022

Comparison of open and robotic-assisted partial nephrectomy approaches using multicentric data (UroCCR-47 study). November 11, 2022

Kidney Tumors: New and Emerging Kidney Tumor Entities. November 11, 2022

A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy. November 10, 2022

Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations. November 10, 2022

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma. November 9, 2022

3D renal model for surgical planning of partial nephrectomy: A way to improve surgical outcomes. November 9, 2022

The incidence and risk factors of chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma. November 8, 2022

IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time. November 7, 2022

Page 62 of 456